Margot, N. A., Wong, P., Kulkarni, R., White, K., Porter, D., Abram, M. E., . . . Miller, M. D. (2017). Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide. The Journal of infectious diseases, 215(6), 920-927. https://doi.org/10.1093/infdis/jix015
Chicago Style (17th ed.) CitationMargot, Nicolas A., Pamela Wong, Rima Kulkarni, Kirsten White, Danielle Porter, Michael E. Abram, Christian Callebaut, and Michael D. Miller. "Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide." The Journal of Infectious Diseases 215, no. 6 (2017): 920-927. https://doi.org/10.1093/infdis/jix015.
MLA (9th ed.) CitationMargot, Nicolas A., et al. "Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide." The Journal of Infectious Diseases, vol. 215, no. 6, 2017, pp. 920-927, https://doi.org/10.1093/infdis/jix015.